المؤلفون: Ferrer-Mileo, L., Rodriguez Hernandez, A., Aversa, C., Rodríguez-Carunchio, L., Ribera, I., Trias Puigsureda, I., Oliva, L., Jimenez Blasco, N., García-Esteve, S., Álvarez, M., Rabella, M., Mellado Gonzalez, B., Torras, O. Reig

المصدر: In Annals of Oncology October 2023 34 Supplement 2:S1220-S1221

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Jiménez N; Translational Genomics and Targeted Therapeutics in Solid Tumors Lab, Fundació de Recerca Clínic Barcelona - Institut d'Investigacions Biomèdiques August Pi i Sunyer (FRCB-IDIBAPS), Barcelona, Spain., Garcia de Herreros M; Translational Genomics and Targeted Therapeutics in Solid Tumors Lab, Fundació de Recerca Clínic Barcelona - Institut d'Investigacions Biomèdiques August Pi i Sunyer (FRCB-IDIBAPS), Barcelona, Spain; Medical Oncology Department, Hospital Clínic, Barcelona, Spain., Reig Ò; Translational Genomics and Targeted Therapeutics in Solid Tumors Lab, Fundació de Recerca Clínic Barcelona - Institut d'Investigacions Biomèdiques August Pi i Sunyer (FRCB-IDIBAPS), Barcelona, Spain; Medical Oncology Department, Hospital Clínic, Barcelona, Spain; Uro-Oncology Unit, Hospital Clínic, University of Barcelona, Barcelona, Spain; Department of Medicine, University of Barcelona, Barcelona, Spain., Marín-Aguilera M; Translational Genomics and Targeted Therapeutics in Solid Tumors Lab, Fundació de Recerca Clínic Barcelona - Institut d'Investigacions Biomèdiques August Pi i Sunyer (FRCB-IDIBAPS), Barcelona, Spain; Medical Oncology Department, Hospital Clínic, Barcelona, Spain., Aversa C; Translational Genomics and Targeted Therapeutics in Solid Tumors Lab, Fundació de Recerca Clínic Barcelona - Institut d'Investigacions Biomèdiques August Pi i Sunyer (FRCB-IDIBAPS), Barcelona, Spain; Medical Oncology Department, Hospital Clínic, Barcelona, Spain; Uro-Oncology Unit, Hospital Clínic, University of Barcelona, Barcelona, Spain., Ferrer-Mileo L; Translational Genomics and Targeted Therapeutics in Solid Tumors Lab, Fundació de Recerca Clínic Barcelona - Institut d'Investigacions Biomèdiques August Pi i Sunyer (FRCB-IDIBAPS), Barcelona, Spain; Medical Oncology Department, Hospital Clínic, Barcelona, Spain; Uro-Oncology Unit, Hospital Clínic, University of Barcelona, Barcelona, Spain., García-Esteve S; Translational Genomics and Targeted Therapeutics in Solid Tumors Lab, Fundació de Recerca Clínic Barcelona - Institut d'Investigacions Biomèdiques August Pi i Sunyer (FRCB-IDIBAPS), Barcelona, Spain; Department of Medicine, University of Barcelona, Barcelona, Spain., Rodríguez-Carunchio L; Uro-Oncology Unit, Hospital Clínic, University of Barcelona, Barcelona, Spain; Department of Pathology, Hospital Clínic, Barcelona, Spain., Trias I; Uro-Oncology Unit, Hospital Clínic, University of Barcelona, Barcelona, Spain; Department of Pathology, Hospital Clínic, Barcelona, Spain., Font A; Medical Oncology Department, Institut Català d'Oncologia, Hospital Germans Trias i Pujol, Badalona, Spain., Rodriguez-Vida A; Medical Oncology Department, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Hospital del Mar, Barcelona, Spain., Climent MÁ; Medical Oncology Service, Instituto Valenciano de Oncología (IVO), Valencia, Spain., Cros S; Medical Oncology Department, Hospital General de Granollers, Barcelona, Spain., Chirivella I; Oncology Department, Hospital Clínico Universitario de Valencia, Valencia, Spain., Domènech M; Medical Oncology Department, Fundació Althaia, Xarxa Assistencial Universitària de Manresa, Spain., Figols M; Medical Oncology Department, Fundació Althaia, Xarxa Assistencial Universitària de Manresa, Spain., Carles J; Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital, Barcelona, Spain., Suárez C; Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital, Barcelona, Spain., Herrero Rivera D; Medical Oncology Department, Hospital Virgen del Rocío, Sevilla, Spain., González-Billalabeitia E; Medical Oncology Department, University Hospital, 12 de Octubre, Madrid, Spain., Cívico C; Department of Hematology and Medical Oncology, Hospital Universitario Morales Meseguer, IMIB-Universidad de Murcia, Murcia, Spain., Sala-González N; Department of Medical Oncology, Institut Català d'Oncologia, Girona, Spain., Ruiz de Porras V; Badalona Applied Research Group in Oncology (B-ARGO), Institut Català d'Oncologia - Germans Trias i Pujol Research Institute, Badalona, Spain., Ribal MJ; Department of Urology, Hospital Clínic, Barcelona, Spain., Prat A; Translational Genomics and Targeted Therapeutics in Solid Tumors Lab, Fundació de Recerca Clínic Barcelona - Institut d'Investigacions Biomèdiques August Pi i Sunyer (FRCB-IDIBAPS), Barcelona, Spain; Medical Oncology Department, Hospital Clínic, Barcelona, Spain; Department of Medicine, University of Barcelona, Barcelona, Spain., Mellado B; Translational Genomics and Targeted Therapeutics in Solid Tumors Lab, Fundació de Recerca Clínic Barcelona - Institut d'Investigacions Biomèdiques August Pi i Sunyer (FRCB-IDIBAPS), Barcelona, Spain; Medical Oncology Department, Hospital Clínic, Barcelona, Spain; Uro-Oncology Unit, Hospital Clínic, University of Barcelona, Barcelona, Spain; Department of Medicine, University of Barcelona, Barcelona, Spain. Electronic address: bmellado@clinic.cat.

المصدر: European urology oncology [Eur Urol Oncol] 2024 Aug; Vol. 7 (4), pp. 954-964. Date of Electronic Publication: 2024 Mar 01.

نوع المنشور: Journal Article; Multicenter Study; Validation Study

بيانات الدورية: Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101724904 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2588-9311 (Electronic) Linking ISSN: 25889311 NLM ISO Abbreviation: Eur Urol Oncol Subsets: MEDLINE

مواضيع طبية MeSH: PTEN Phosphohydrolase*/genetics , Tumor Suppressor Protein p53*/genetics , Tumor Suppressor Protein p53*/metabolism , Retinoblastoma Binding Proteins*/genetics, Humans ; Male ; Retrospective Studies ; Aged ; Prognosis ; Ubiquitin-Protein Ligases/genetics ; Prostatic Neoplasms, Castration-Resistant/drug therapy ; Prostatic Neoplasms, Castration-Resistant/genetics ; Prostatic Neoplasms, Castration-Resistant/pathology ; Prostatic Neoplasms, Castration-Resistant/mortality ; Middle Aged ; Transcriptome ; Neoplasm Metastasis ; Androgen Antagonists/therapeutic use ; Aged, 80 and over ; Prostatic Neoplasms/genetics ; Prostatic Neoplasms/drug therapy ; Prostatic Neoplasms/pathology